Related references
Note: Only part of the references are listed.CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary
Ignacio Melero et al.
CANCER DISCOVERY (2023)
Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity
Assunta Cirella et al.
CANCER IMMUNOLOGY RESEARCH (2023)
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors
Ignacio Melero et al.
SCIENCE TRANSLATIONAL MEDICINE (2023)
TGF-β orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer
Luciana Gneo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)
NHS-IL12 and bintrafusp alfa combination therapy enhances antitumor activity in preclinical cancer models
Chunxiao Xu et al.
TRANSLATIONAL ONCOLOGY (2022)
Advances in mRNA-based drug discovery in cancer immunotherapy
Claudia Augusta Di Trani et al.
EXPERT OPINION ON DRUG DISCOVERY (2022)
RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System
Wout De Mey et al.
CLINICAL CANCER RESEARCH (2022)
Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer Immunotherapy
Zihai Li et al.
CANCER DISCOVERY (2022)
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
Alexander Muik et al.
CANCER DISCOVERY (2022)
The landscape of mRNA nanomedicine
Xiangang Huang et al.
NATURE MEDICINE (2022)
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Tae Won Kim et al.
CLINICAL CANCER RESEARCH (2022)
Novel strategies exploiting interleukin-12 in cancer immunotherapy
Assunta Cirella et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Intratumoral electroporation of a self-amplifying RNA expressing IL-12 induces antitumor effects in mouse models of cancer
Noelia Silva-Pilipich et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
Preliminary safety, antitumor activity and pharmacodynamics results of HIT-IT MEDI1191 (mRNA IL-12) in patients with advanced solid tumours and superficial lesions
O. Hamid et al.
ANNALS OF ONCOLOGY (2021)
Oncolytic virotherapy as immunotherapy
Alan Melcher et al.
SCIENCE (2021)
CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function
Mariona Cabo et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Novel therapies emerging in oncology to target the TGF-β pathway
Byung-Gyu Kim et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Ignacio Melero et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
The Next Decade of Immune Checkpoint Therapy
Padmanee Sharma et al.
CANCER DISCOVERY (2021)
Current strategies for intratumoural immunotherapy-Beyond immune checkpoint inhibition
Jianda Yuan et al.
EUROPEAN JOURNAL OF CANCER (2021)
Local delivery of mRNA-encoding cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models
Christian Hotz et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors
Martin Gutierrez et al.
CLINICAL CANCER RESEARCH (2021)
Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients
A. Algazi et al.
ANNALS OF ONCOLOGY (2020)
Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses
Samantha K. Greaney et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Amplifying RNA Vaccine Development
Deborah H. Fuller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment
Susannah L. Hewitt et al.
CLINICAL CANCER RESEARCH (2020)
Interleukin-12 Message in a Bottle
Assunta Cirella et al.
CLINICAL CANCER RESEARCH (2020)
Localized Interleukin-12 for Cancer Immunotherapy
Khue G. Nguyen et al.
FRONTIERS IN IMMUNOLOGY (2020)
TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies
Maria E. Rodriguez-Ruiz et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
Susannah L. Hewitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Transforming Growth Factor-β Signaling in Immunity and Cancer
Eduard Batlle et al.
IMMUNITY (2019)
Twists and turns to translating 4-1BB cancer immunotherapy
Miguel F. Sanmamed et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
Shihong Zhang et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Cytokines in clinical cancer immunotherapy
Pedro Berraondo et al.
BRITISH JOURNAL OF CANCER (2019)
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+T Cells
Inaki Etxeberria et al.
CANCER CELL (2019)
CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapy
Siqi Chen et al.
NATURE COMMUNICATIONS (2019)
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors
Julius Strauss et al.
CLINICAL CANCER RESEARCH (2018)
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
Yan Lan et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
An RNA toolbox for cancer immunotherapy
Fernando Pastor et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)
A. Marabelle et al.
ANNALS OF ONCOLOGY (2018)
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
Marta Compte et al.
NATURE COMMUNICATIONS (2018)
Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally
M. Angela Aznar et al.
JOURNAL OF IMMUNOLOGY (2017)
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
Christiane R. Stadler et al.
NATURE MEDICINE (2017)
Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment
Sadna Budhu et al.
SCIENCE SIGNALING (2017)
Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment
Sadna Budhu et al.
SCIENCE SIGNALING (2017)
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
Alfonso R. Sanchez-Paulete et al.
CANCER DISCOVERY (2016)
Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
Sandra Van Lint et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade
Jose I. Quetglas et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity
Kevin Van der Jeught et al.
Oncotarget (2015)
Intratumoral Immunization: A New Paradigm for Cancer Therapy
Aurelien Marabelle et al.
CLINICAL CANCER RESEARCH (2014)
Orchestrating immune check-point blockade for cancer immunotherapy in combinations
Jose Luis Perez-Gracia et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
John C. Morris et al.
PLOS ONE (2014)
The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis
Kendra Garrison et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Immunotherapeutic Synergy Between Anti-CD137 mAb and Intratumoral Administration of a Cytopathic Semliki Forest Virus Encoding IL-12
Jose I. Quetglas et al.
MOLECULAR THERAPY (2012)
Development of a Liver-specific Tet-On Inducible System for AAV Vectors and Its Application in the Treatment of Liver Cancer
Lucia Vanrell et al.
MOLECULAR THERAPY (2011)
CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-β-dependent manner
John Andersson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Cutting edge:: Autocrine TGF-β sustains default tolerogenesis by IDO-competent dendritic cells
Maria L. Belladonna et al.
JOURNAL OF IMMUNOLOGY (2008)
Enhancing antitumor immunity:: Combining IL-12 with TGFβ1 antagonism
Timothy M. Fan et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Dendritic cells with TGF-β1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells
Xunrong Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas
JR Rodriguez-Madoz et al.
MOLECULAR THERAPY (2005)
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi
ML Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Development of TGF-β signalling inhibitors for cancer therapy
JM Yingling et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
WJ Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Synergy of IL-12 and IL-18 for IFN-γ gene expression:: IL-12-induced STAT4 contributes to IFN-γ promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1
M Nakahira et al.
JOURNAL OF IMMUNOLOGY (2002)
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
L Gorelik et al.
NATURE MEDICINE (2001)
Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation
SH Chen et al.
MOLECULAR THERAPY (2000)
Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
L Gorelik et al.
IMMUNITY (2000)
Share Paper
